Mitochondrial depolarization in VSM with diazoxide, an activator of mitochondrial ATP-sensitive potassium (mito-K ATP ) channels, promotes the generation of reactive oxygen species (ROS) from mitochondria, which sequentially causes the activation of ryanodine-sensitive Ca 2+ channels on sarcoplasmic reticulum, generation of calcium transients, otherwise known as calcium sparks, and the opening of adjacent largeconductance calcium-activated potassium channels (BK Ca ) on the plasma membrane. The efflux of K + thus leads to hyperpolarization, decreased global intracellular Ca 2+ of VSM, and vasodilation.
M itochondria appear to play an important role in the regulation of cerebral vascular tone. Recent, limited evidence shows that mitochondria-derived factors promote relaxation of intact or endothelium-denuded cerebral arteries or isolated vascular smooth muscle (VSM) cells. endothelium-dependent vasodilation cannot be elucidated from previous studies. The ability of endothelial mitochondrial depolarization to affect cerebrovascular tone is a novel and potentially important area of investigation, as many physiological, pharmacological, pathological, and physical factors impacting endothelium has been shown in other regional circulations, [5] [6] [7] [8] [9] [10] [11] but not yet in the cerebral circulation. Two relatively selective openers of mitoK ATP channels, diazoxide and BMS-191095 (BMS), are available, and we have studied their properties extensively in isolated mitochondria, cultured neurons, and astrocytes. [12] [13] [14] [15] [16] Although both depolarize mitochondria, diazoxide, but not BMS, causes increased production of ROS from mitochondria presumably by inhibiting succinate dehydrogenase. 17 We 12, 13, 16 and others [18] [19] [20] [21] are unaware of any effects of BMS other than as an opener of mitoK ATP channels. No previous studies have examined the effects of BMS on cerebral arterial tone, and the endotheliumspecific effects of diazoxide have not been specifically studied. In this study, we examined the effect of mitochondrial depolarization in endothelium on integrated cerebral vascular tone and explored the mechanisms involved. Our results have allowed us to document the key elements of signaling steps that link mitochondrial depolarization with the generation of nitric oxide (NO) by cerebral vascular endothelium, including activation of endothelial nitric oxide synthase (eNOS) by dual pathways involving increased [Ca 2+ ] i as well as by phoshpoinositide 3-kinase (PI3K)-protein kinase B (Akt)-induced phosphorylation.
Results

Intraluminal Diameter Measurements
The resting diameters of the cerebral arteries were similar for each group of experiments (169±4, n=91, in endotheliumintact and 163±4, n=19, in endothelium-denuded; P=NS), and they were preconstricted to a similar degree (52±1, n=34, in endothelium-intact and 51±2, n=14, in endothelium-denuded; P=NS). The BMS elicited a dose-dependent vasodilation in cerebral arteries with 16.3±1.4%, 49.7±4.7%, and 62.6±4.4% relaxation in response to 10, 50, and 100 µmol/L, respectively (n=6-12). Similarly, diazoxide elicited a dosedependent vasodilation with 8.9±1.2%, 21.9±2.9%, and 39.5±2.8% relaxation in response to 10, 50, and 100 µmol/L, respectively (n=10; Figure 1 ). Denudation of endothelium diminished vasodilation to BMS with 5.9±0.9%, 31.6±2.1%, and 38.1±3.8% relaxation in response to 10, 50, and 100 µmol/L, respectively (n=10; P<0.05). Similarly, denudation of endothelium diminished vasodilation to diazoxide with 4.8±1.3%, 11.7±3.5%, and 28.5±2.3% relaxation in response to 10, 50, and 100 µmol/L, respectively (n=9; P<0.05; Figure 1 ). Thus, endothelium contributes to vasodilation in response to both BMS and diazoxide.
Scavenging of the ROS with MnTBAP did not affect vasodilation to BMS (51.1±4.3, n=5; P=NS) confirming that BMS-induced vasodilation was independent of ROS generation ( Figure 2A ). In contrast, MnTBAP diminished vasodilation to diazoxide (8.6±1.3, n=5; P<0.05) confirming that diazoxide-induced vasodilation was ROS-dependent ( Figure 2B ). Inhibition of mitoK ATP channels alone with 5-hydroxydeconoic acid (11.7±2%, n=14; P<0.05) and fluoxetine (19.5±4%, n=5; P<0.05), or both mitochondrial and plasma membrane K ATP with glibenclamide (22.3±4%, n=6; P<0.05) decreased vasodilation to BMS in endothelium-intact arteries (Figure 2A ). Wortmannin pretreatment (10, 50 , and 100 µmol/L) in endothelium-intact and -denuded cerebral arteries from Sprague Dawley (SD) rats after development of myogenic tone are shown. Data are mean±SEM of 6 to 14 experiments. * and † indicate significant difference in corresponding response in endothelium-intact arteries with respect to BMS and diazoxide, respectively (P<0.05). (Figure 2A and 2B). Arteries took ≈20 to 30 minutes to attain a stable diameter both before and after the administration of pharmacological agents. In general, addition of pharmacological blockers had minimal effects on the diameter of preconstricted arteries. When compared with vehicle-treated arteries (0.5±0.4%, n=27), pretreatment with L-NAME (8.9±1.2%, n=14; P<0.05) caused slight constriction of arteries, whereas pretreatment with wortmannin (8.2±5%, n=5; P<0.05) caused only slight vasodilation. However, pretreatment with MnTBAP (0.45±0.7%, n=10), 5-hydroxydeconoic acid (0.6±1%, n=14), fluoxetine (-0.7±4%, n=5), and glibenclamide (-0.1±1%, n=6) had no significant effect on vascular diameter.
BMS-191095 or
Mitochondrial Membrane Potential, [Ca2+]i, NO, and Mitochondrial ROS Measurements
The BMS and diazoxide depolarized the mitochondria of CMVECs indicated by reduction of rhodamine 123 fluorescence compared with vehicle-treated cells ( Figure 3A and 3E). Background subtracted rhodamine 123 fluorescence .3±11%, controls of BMS and diazoxide, respectively; n=6 each), however, this was a result of reduction in basal NO production that was sensitive to L-NAME. Thus, the increase in DAF fluorescence in response to BMS and diazoxide correlated with NOSderived NO production ( Figure 3C 
NO Measurements by ESR
A characteristic NO-Fe(DETC) 2 signal with 3 peaks (g value ≈2.035) was detected in rat aortas incubated with Fe(DETC) 2 and various drugs. The magnitude of this signal was greatly increased by stimulation with the BMS (194±21%, n=6; P<0.05) or diazoxide (232±19%, n=6; P<0.05) compared with vehicle-treated aortas (100±0%, n=6; Figure 3D and 3G). Furthermore, the ESR signals from BMS-or diazoxidestimulated aortas were abolished after addition of the NOS inhibitor, L-NAME. Figure 5A and 5D). In addition, the phosphorylated-eNOS/total-eNOS Figure 5B and 5E). Thus, pretreatment of CMVECs and arteries with wortmannin eliminated the increase in eNOS phosphorylation in response to diazoxide.
Akt and eNOS Phosphorylation
Discussion
There are 4 major, new findings of the study. First, mitochondrial depolarization in the presence as well as in the absence of ROS generation is a potent initiator of dilator responses of cerebral arteries. Second, mitochondrial depolarizationinduced relaxation involves contributions from endothelium as well as VSM. Third, the endothelium-dependent vasodilation induced by mitochondrial depolarization is mediated by NO resulting from activation of eNOS via increased endothelial [Ca 2+ ] i and activation of PI3K leading to Akt phosphorylation. Fourth, both mitochondrial ROS-dependent and -independent mechanisms are capable of promoting vasodilation by mitochondrial depolarization. Our observations indicate that mitochondrial factors specific to depolarization can have major influences on the regulation of cerebral vascular tone.
Our finding that activation of mitoK ATP channels elicited vasodilation is consistent with previous studies from our laboratory 3 and others, 2 and in addition, demonstrates the importance of the endothelium. Scavenging of ROS reduced the vasodilation response to diazoxide alone, whereas BMSinduced vasodilation was unaffected. Thus, the ability of mitochondrial depolarization by BMS to promote vasodilation independent of ROS generation is a novel observation. Measurements of mitochondrial ROS in endothelial cells provided additional evidence that, unlike diazoxide, BMS does not enhance the generation of mitochondrial ROS. Furthermore, reduced vasodilation in response to BMS and diazoxide after endothelial denudation confirmed the important contribution of endothelium to mitochondria-mediated vasodilation. Notably, the greater endothelial contribution to vasodilation in response to BMS versus diazoxide suggests that the ROS production by diazoxide may interfere with NO-dependent mechanisms.
Mitochondria-mediated vasodilation was also sensitive to inhibition of mitoK ATP channels confirming their role in mitochondrial depolarization. Studies in our laboratory and others have demonstrated the role of mitoK ATP channels in mediating the effects of diazoxide 2, 14, 22 and BMS 3, 12, 13, 16, 18, 19, 21, 23, 24 in isolated mitochondria, neurons, vasculature, and cardiomyocytes. Also, our laboratory has characterized the distinct ROS-independent mechanism of actions of BMS compared with diazoxide in isolated mitochondria and cultured cortical neurons. 12, 16 The present study confirms our previous findings of ROS-independent actions of BMS in promoting mitochondria-mediated vasodilation.
Inhibition of NOS diminished vasodilation to BMS and diazoxide in endothelium-intact arteries indicating that part of the mitochondria-mediated vasodilation was NO-dependent vasodilation. This finding is consistent with our previous observations, which showed that diazoxide-induced vasodilation involved endothelium and NOS. 3 Moreover, fluorescence measurements of NO in CMVECs confirmed the ability of BMS and diazoxide to enhance NO generation sensitive to NOS inhibition. Furthermore, measurements of NO by ESR provided additional evidence supporting the ability of BMS and diazoxide to promote NO generation in vascular tissues. Two potential mechanisms underlie the activation of eNOS in response to BMS and diazoxide: First, fluorescence measurements of Ca 2+ showed elevation of intracellular Ca 2+ in response to mitochondrial depolarization in CMVECs and also in endothelial cells of intact cerebral arteries, thus implicating [Ca 2+ ] i in the production and release of endothelial-relaxing factors. Second, administration of wortmannin resulted in diminished vasodilation in response to BMS and diazoxide, implicating the PI3K pathway in vasodilation. Mitochondrial depolarization initiates key elements of cellular signaling, such as activation of Akt or increases in [Ca 2+ ] i , events which are associated with direct effects on VSM and production of endothelium-dependent relaxing factors, such as NO and prostacyclin. 3 For example, we have recently shown that insulin dilates cerebral arteries after activation of the PI3K and Akt system. 25 Our findings showing that wortmannin reduced vasodilation to BMS and diazoxide are consistent with this mechanism, and similar findings have been reported in heart. 21 In addition, BMS and diazoxide treatment of CMVECs and arteries promoted phosphorylation of Akt consistent with involvement of PI3K-Akt pathway in vasodilation. 26 Our previous studies reported for the first time that mitochondrial depolarization leads to the activation of PI3K-Akt signaling pathway in cultured neurons, 12 as opposed to PI3K-Akt pathway activation leading to alteration of mitochondrial membrane potential. 27 Mitochondrial depolarization has been shown to increase localized calcium transients in the form of Ca 2+ sparks in VSM 2 without significant change in global [Ca 2+ ] i , however, the exact mechanisms by which mitochondrial depolarization leads to an increase in [Ca 2+ ] i , and activation of PI3K in endothelial cells needs further investigation. We believe that the mechanisms underlying the release of NO are likely to promote the release of non-NO factors, such as hydrogen peroxide, prostacyclin, and so on, contributing to mitochondria-mediated vasodilation. Furthermore, treatment of cerebral arteries and CMVECs with BMS and diazoxide resulted in increased phosphorylation of eNOS, further confirming the activation of eNOS by mitochondrial depolarization. Finally, wortmannin abolished the diazoxideinduced increase in phosphorylation of eNOS in both CMVECs and arteries confirming the role of the PI3K pathway in mitochondria-mediated vasodilation.
Although this is a relatively new field of study, it appears that diverse physiological, pathological, and pharmacological factors can depolarize mitochondria in vascular cells. Depolarization of mitochondria in other nonvascular cells within the neurovascular unit, such as astroglia and neurons, might also lead to the production and release of substances, which could affect cerebral vascular tone. Thus, increased shear stress in coronary arteries, possibly through filamentous connections with the glycocalyx, can distort and activate mitochondrial-driven events resulting in production of dilator agents, such as hydrogen peroxide in mitochondria. 28 Similarly, decreased oxygen levels can affect mitochondrial membrane potential in blood vessels.
2,10 Furthermore, we have shown that drugs such as rosuvastatin also depolarize mitochondria in neurons. 29 Thus, our findings have demonstrated for the first time the ability of mitochondrial depolarization to promote the release of endothelial-relaxing factors via increased [Ca 2+ ] i and the PI3K-Akt-eNOS pathway.
Limitations
Our studies used pharmacological approaches to promote mitochondrial depolarization, and agents such as diazoxide have been shown to exhibit some nontarget and nonspecific mitochondrial effects. Many physiological/pathological stimuli (hypoxia) 30 ,31 that promote mitochondrial depolarization are plagued by similar, but significantly greater ] i -independent activation of eNOS leading to NO generation. Finally, mitochondrial depolarizationinduced endothelium-dependent vasodilation is primarily mediated by NO, and this effect enhances vascular smooth muscle (VSM)-specific relaxation. Mitochondrial depolarization in VSM cells sequentially causes the activation of ryanodine-sensitive Ca 2+ channels on sarcoplasmic reticulum, generation of calcium transients, calcium sparks, and the opening of adjacent largeconductance calcium-activated potassium channels (BK Ca ) on the plasma membrane. The efflux of K + thus leads to hyperpolarization, decreased global intracellular Ca 2+ of smooth muscle, and vasodilation. 
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